Alterola Biotech (Alterola Biotech) Accounts Payable & Accrued Expense : $1.11 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Alterola Biotech Accounts Payable & Accrued Expense?

Alterola Biotech's quarterly accounts payable & accrued expense increased from Jun. 2023 ($0.96 Mil) to Sep. 2023 ($0.97 Mil) and increased from Sep. 2023 ($0.97 Mil) to Dec. 2023 ($1.11 Mil).

Alterola Biotech's annual accounts payable & accrued expense increased from Sep. 2020 ($0.34 Mil) to Mar. 2022 ($0.94 Mil) but then declined from Mar. 2022 ($0.94 Mil) to Mar. 2023 ($0.87 Mil).

Alterola Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Alterola Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech Accounts Payable & Accrued Expense Chart

Alterola Biotech Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.09

0.22

0.34

0.94

0.87

Alterola Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.68	0.87	0.96	0.97	1.11

Alterola Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Alterola Biotech (Alterola Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR

Website

https://www.alterolabio.com

Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.

Executives

Bright Green Corp

10 percent owner

401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301